Scynexis SCYX
NASDAQ SCYX
$4.91 -0.24 (-4.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scynexis (SCYX) Current Deferred Revenue (2013 - 2026)

Scynexis' (SCYX) quarterly Current Deferred Revenue came in at $235000.0 in Q1 2026, down 91.9% on a YoY basis from $2.9 million in Q1 2025, and little changed quarter-over-quarter from $235000.0 in Q4 2025.

Analysis

Scynexis (SCYX) Current Deferred Revenue (2013 - 2026) Analysis & Trends

Scynexis (SCYX) has reported Current Deferred Revenue for 11 consecutive years, with $235000.0 the latest figure, recorded in Q1 2026.

  • For the quarter ending Q1 2026, Current Deferred Revenue fell 91.9% year-over-year to $235000.0; the trailing twelve-month figure through Mar 2026 stood at $235000.0 (down 91.9% YoY), and the FY2025 full-year result was $235000.0, down 85.69% from the prior year.
  • Current Deferred Revenue held at $235000.0 in Q1 2026 per SCYX's latest filing, from $235000.0 in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $3.2 million in Q2 2023 and bottomed at $235000.0 in Q4 2025.
  • Historically, Current Deferred Revenue has averaged $1.7 million across 4 years, with a median of $1.6 million in 2024.
  • The sharpest annual moves came in 2025 and 2026: Current Deferred Revenue jumped 163.64% in 2025, then slumped 91.9% in 2026.
  • Over 4 years, Current Deferred Revenue stood at $1.2 million in 2023, then surged by 38.1% to $1.6 million in 2024, then slumped by 85.69% to $235000.0 in 2025, then changed by 0.0% to $235000.0 in 2026.
  • According to Business Quant data, Current Deferred Revenue over the past three periods registered $235000.0, $235000.0, and $1.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn
10 Scynexis 58.41 Mn -56.29 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 235,000.00
Dec 31, 2025 235,000.00
Sep 30, 2025 1.80 Mn
Jun 30, 2025 2.30 Mn
Mar 31, 2025 2.90 Mn
Dec 31, 2024 1.64 Mn
Sep 30, 2024 1.64 Mn
Jun 30, 2024 1.23 Mn
Mar 31, 2024 1.10 Mn
Dec 31, 2023 1.19 Mn
Sep 30, 2023 2.44 Mn
Jun 30, 2023 3.23 Mn
Mar 31, 2019 54,000.00
Dec 31, 2018 121,000.00
Sep 30, 2018 185,000.00
Jun 30, 2018 249,000.00
Mar 31, 2018 257,000.00
Dec 31, 2017 257,000.00
Sep 30, 2017 257,000.00
Jun 30, 2017 257,000.00